Contact

Home
About us
Team
Companies
Stories
ESG
News

Home
About us
Team
Companies
Stories
ESG
News
Contact

Keensight Capital invests in Biovian, a leading biopharmaceutical contract development and manufacturing organization (CDmO)

By WeAreBlow May 23, 2018 February 1st, 2019 No Comments

Download Télécharger

Previous PostTheodor Wuppermann joins Keensight Capital as Associate Director
Next PostPIXID continues European expansion with acquisition of Dutch staffing CRM supplier Carerix

About us
Team
Companies

News
Stories
Contact

Terms & conditions
Credits